How to Buy Madrigal Pharmaceuticals Stock
Madrigal Pharmaceuticals Inc
Madrigal Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases.
Madrigal Pharmaceuticals stock last closed at $333.91, down 2.02% from the previous day, and has increased 63.67% in one year. It has overperformed other stocks in the Biotechnology industry by 1.41 percentage points. Madrigal Pharmaceuticals stock is currently +66.89% from its 52-week low of $200.08, and -11.54% from its 52-week high of $377.46.
As of Apr 30, 2025, there are 22.08M MDGL shares outstanding. The market value of MDGL is $7.37B. In the last 24 hours, 412,942 MDGL shares were traded.
How to Buy Madrigal Pharmaceuticals Stock
Not sure how to invest in Madrigal Pharmaceuticals stock? Here's how.
- Choose where to buy Madrigal Pharmaceuticals stock: You need to choose an online brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you decide where to buy Madrigal Pharmaceuticals stock.
- Sign up for a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Deposit money your brokerage account: Pick your payment method and add your details.
- Research Madrigal Pharmaceuticals stock: The Madrigal Pharmaceuticals ticker symbol is MDGL. Is Madrigal Pharmaceuticals stock a good investment? Should you buy shares of MDGL? How do MDGL's underlying business fundamentals look? Do top analysts think Madrigal Pharmaceuticals is a good buy? Why has MDGL's stock price moved recently? (Hint: Our stock analysis website can help you decide if MDGL is a good stock to buy).
- Make your MDGL purchase: Decide if you will purchase MDGL shares at the current market price or use a limit order to buy MDGL stock at a given price.
- Get key alerts regarding your MDGL investment: Create a watchlist to get live updates on your position in Madrigal Pharmaceuticals stock.
Step 1: Choose where to buy Madrigal Pharmaceuticals stock
You will need a brokerage account in order to access the NASDAQ market and buy MDGL shares.
Our preferred brokerage: eToro
Based on our research, eToro is the best brokerage. eToro gives you:
- Invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to global markets: From Tech to Financial Services, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading stock exchanges.
- Social investing: eToro boasts a community with more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by signing up for an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Sign up for a brokerage account
Now that you've picked the right brokerage, you'll need to fill out some personal details so you are able to invest in MDGL stock today.
How to Create a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal data to start your new trading account.
- Submit your details by pressing the "Create Account" button. Get started with eToro today
Step 3: Deposit money your brokerage account
Now that you've filled out your info on app for stock, your next step is to transfer the money for your investment:
Check out the tutorial below to see the process of depositing money into your investment account.
Step 4: Research Madrigal Pharmaceuticals stock
Once you have chosen the best place to buy Madrigal Pharmaceuticals stock, it's crucial to research their stock prior to buying, so you truly understand the risk as well as the opportunity.
Madrigal Pharmaceuticals quick stats
Madrigal Pharmaceuticals Overview
WallStreetZen was designed to help average investors do more accurate fundamental analysis quickly.
You can view all of the due diligence checks on MDGL's stock page.
How is MDGL stock valued?
Investors use a variety of different financial metrics, analyses, models, and charts to gauge MDGL's intrinsic value.
Using relative valuations methods:
- MDGL may be overvalued based on its P/B ratio of 9.77x, relative to Biotechnology industry P/B ratio of 4.45x
You can access additional valuation research on MDGL's stock here.
A quick look at MDGL Financials
Signs that MDGL is financially healthy:
- There are more short-term assets than short-term liabilities on the MDGL balance sheet.
- MDGL has a low debt to equity ratio of 0.38.
- There are more short-term assets than long-term liabilities on the MDGL balance sheet.
- MDGL has cash burn of 462034000. It has sufficient cash and short-term investments to cover this for at least one year.
Signs that MDGL is not financially healthy:
- MDGL has $931.25M in cash and short term investments. This is not enough to cover its annual cash burn of $462.03M.
- MDGL profit margin has gone down from N/A to -258.6% in the past year.
- Total MDGL debt is higher than 5 years ago, relative to shareholder equity.
Is it a good time to buy Madrigal Pharmaceuticals stock, according to Wall Street analysts?
Out of 5 Wall Street analysts who track MDGL, the consensus analyst rating on Madrigal Pharmaceuticals is a Buy
Please note that analyst ratings are not stock recommendations, nor are they financial advice.
You can dive deeper into what analysts are saying on the Madrigal Pharmaceuticals stock forecast page.
MDGL Trading Indicators
What are MDGL insiders up to?
In the past year, insiders at MDGL have sold more shares than they have bought.
Richard S. Levy, Director of MDGL, was the latest MDGL insider to buy. They bought $616,118.20 worth of MDGL stock on Apr 10, 2025.
Learn more about who owns MDGL stock here.
Can I get consistent income from MDGL stock?
No, Madrigal Pharmaceuticals doesn't provide an income stream by paying out dividends.
What do other traders have to say about MDGL?
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other traders have to say.
Step 5: Make your MDGL purchase
There are two main order types:
- Market order: A market order is an order to buy or sell a security at the best possible price.
Market orders are mostly fine for most investors. - Limit order: A limit order lets you buy or sell a stock at a specific price (or better).
If you want to be sure you're buying or selling at a given price, use a limit order.
Press the Open Trade button and eToro will execute the order.
If you want more assistance buying stocks on eToro, watch the how to video below:
Step 6: Get key alerts regarding your MDGL investment
Now that you own some MDGL stock, you'll want to keep up with your investment.
Make a watchlist to see the latest developments about your MDGL stock.
MDGL Feed
How to Buy Stock in Madrigal Pharmaceuticals
To reiterate, here are the 6 steps you need to take to buy Madrigal Pharmaceuticals stock right now:
- Choose where to buy Madrigal Pharmaceuticals stock
- Sign up for a brokerage account
- Deposit money your brokerage account
- Research Madrigal Pharmaceuticals stock
- Make your MDGL purchase
- Get key alerts regarding your MDGL investment
If you need a place to buy stocks, eToro is our favorite option.
Get Started with eToro TodayIf you want to keep track of your investment in Madrigal Pharmaceuticals, create a watchlist today.
Other "How To" Guides You May Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.